David Largaespada, PhD

Dr. David Largaespada is an internationally recognized leader in the study of sarcomas. His work is focused on malignant peripheral nerve sheath tumors (MPNST) and osteosarcomas. He is studying the genetic pathways that cause these diseases and finding unique vulnerabilities that can be exploited for treatment. He is currently submitting an Investigational New Drug application to the Food and Drug Administration for a new combination drug treatment for MPNST.  He has published over 210 papers and is an American Cancer Society Research Professor. Dr. Largaespada is a full professor in the Departments of Pediatrics and Genetics, Cell Biology, and Development and the Associate Director for Basic Research in the Masonic Cancer Center at University of Minnesota. He also serves as the Co-Director of the Brain Tumor Program, MCC and a faculty member of four additional UMN graduate programs. Dr. Largaespada holds the Hedberg Family/CCRF Endowed Chair in Brain Tumor Research.